BackEmmaus Life Sciences Overview

Emmaus Life Sciences Current Cash

Emmaus Life Sciences's current cash is $2.8M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$2.81M
↑ 216.93% YoYΔ $1.92M vs prior year quarter

Peer trimmed avg / median

Loading

Emmaus Life Sciences Current Cash History

Loading

Emmaus Life Sciences vs. peers: Current Cash Comparison

Loading

Emmaus Life Sciences Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Emmaus Life Sciences (EMMA) FAQ

Emmaus Life Sciences posts a current cash of $2.8M as of June 2026. That compares with $890K in the prior-year period — up 216.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Emmaus Life Sciences's current cash was $890K. The latest reading is $2.8M — a 216.9% year-over-year increase (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Emmaus Life Sciences's financial statement story. At $2.8M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for EMMA's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Emmaus Life Sciences's other metric pages and overview cover the third.

Judging Emmaus Life Sciences against Healthcare peers is usually better than using a market-wide rule of thumb. Business models inside Healthcare are more comparable, which makes gaps in current cash easier to interpret. Start with $2.8M here, then scan peer and history charts to see if the gap is persistent.